TABLE 2.
Normal | Elevated | Stage 1 | Stage 2 | |||||
---|---|---|---|---|---|---|---|---|
Standardized % (95% CI) | n | Standardized % (95% CI) | n | Standardized % (95% CI) | n | Standardized % (95% CI) | n | |
Overall | 39.6 (34.1–45.1) | 145 | 20.2 (16.5–23.9) | 74 | 24.6 (16.5–23.9) | 90 | 15.5 (12.6–18.6) | 57 |
Sex | ||||||||
Male | 36.9 (29.9–43.9) | 79 | 21.5 (16.8–26.2) | 46 | 25.7 (19.7–31.7) | 55 | 15.9 (10.5–21.3) | 34 |
Female | 43.4 (36.7–50.1) | 66 | 18.4 (12.6–24.2) | 28 | 23.0 (17.8–28.3) | 35 | 15.1 (10.8–19.4) | 23 |
Age | ||||||||
<10 y | 41.9 (35.8–47.9) | 124 | 17.2 (13.7–20.7) | 51 | 26.0 (20.6–31.4) | 77 | 14.9 (10.7–19.0) | 44 |
≥10 y | 30 (20.6–39.4) | 21 | 32.9 (22.3–43.4) | 23 | 18.6 (10.7–26.4) | 13 | 18.6 (10.2–27.0) | 13 |
BMI | ||||||||
<85% | 45.7 (38.9–52.6) | 75 | 20.1 (15.6–24.7) | 33 | 23.2 (18.3–28.1) | 38 | 11.0 (6.4–15.6) | 18 |
85%–95% | 32.7 (18.3–47.1) | 18 | 20.0 (10.2–29.8) | 11 | 20.0 (8.6–31.4) | 11 | 27.3 (14.9–39.7) | 15 |
>95% | 35.4 (28.4–42.3) | 52 | 20.4 (14.1–26.7) | 30 | 27.9 (22.1–33.7) | 41 | 16.3 (10.4–22.2) | 24 |
CI, confidence interval.